Gene · 871
Papers3,090
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,101 to 1,120 of 3,090
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Safety profiles of terahertz scanning in ophthalmology. | Sci Rep | 2021 | 33510290 | PubTator, text mining | PubMed |
| Human T-cell lymphotropic virus type 1 transmission dynamics in rural villages in the Democratic Republic of the Congo with high nonhuman primate exposure. | PLoS Negl Trop Dis | 2021 | 33507996 | PubTator, text mining | PubMed |
| Novel Genetic Constructs for Production of Recombinant HTLV-1/2 Antigens and Evaluation of Their Reactivity to Plasma Samples from HTLV-1-Infected Patients. | J Clin Microbiol | 2021 | 33504592 | PubTator, text mining | PubMed |
| Osteogenesis Imperfecta in neonatal period in Cameroon: A case report. | Clin Case Rep | 2021 | 33489208 | PubTator, text mining | PubMed |
| Tumour inflammation signature and expression of S100A12 and HLA class I improve survival in HPV-negative hypopharyngeal cancer. | Sci Rep | 2021 | 33469045 | PubTator, text mining | PubMed |
Estimation of the carrier frequencies and proportions of potential patients by detecting causative gene variants associated with autosomal recessive bone dysplasia using a whole-genome reference panel of Japanese individuals. | Hum Genome Var | 2021 | 33452237 | PubTator, text mining | PubMed |
| The versatile role of exosomes in human retroviral infections: from immunopathogenesis to clinical application. | Cell Biosci | 2021 | 33451365 | PubTator, text mining | PubMed |
| Acute perturbation strategies in interrogating RNA polymerase II elongation factor function in gene expression. | Genes Dev | 2021 | 33446572 | PubTator, text mining | PubMed |
| The Use of Alternative Strategies for Enhanced Nanoparticle Delivery to Solid Tumors. | Chem Rev | 2021 | 33445874 | PubTator, text mining | PubMed |
| IFN-γ+ CD4+T cell-driven prophylactic potential of recombinant LDBPK_252400 hypothetical protein of Leishmania donovani against visceral leishmaniasis. | Cell Immunol | 2021 | 33445051 | PubTator, text mining | PubMed |
| Epithelial p53 Status Modifies Stromal-Epithelial Interactions During Basal-Like Breast Carcinogenesis. | J Mammary Gland Biol Neoplasia | 2021 | 33439408 | PubTator, text mining | PubMed |
| Experimental Study of Burn Damage Progression in a Human Composite Tissue Model. | Biology (Basel) | 2021 | 33435601 | PubTator, text mining | PubMed |
| Mitochondrial Structure and Bioenergetics in Normal and Disease Conditions. | Int J Mol Sci | 2021 | 33435522 | PubTator, text mining | PubMed |
| Mechanisms of Bone Fragility: From Osteogenesis Imperfecta to Secondary Osteoporosis. | Int J Mol Sci | 2021 | 33435159 | PubTator, text mining | PubMed |
| A novel human ex vivo skin model to study early local responses to burn injuries. | Sci Rep | 2021 | 33432026 | PubTator, text mining | PubMed |
| Seroprevalence of human T-lymphotropic virus infection among blood donors in China: a first nationwide survey. | Retrovirology | 2021 | 33413457 | PubTator, text mining | PubMed |
| Interacting with Hemoglobin: Paracoccidioides spp. Recruits hsp30 on Its Cell Surface for Enhanced Ability to Use This Iron Source. | J Fungi (Basel) | 2021 | 33401497 | PubTator, text mining | PubMed |
| Predicting changes in renal metabolism after compound exposure with a genome-scale metabolic model. | Toxicol Appl Pharmacol | 2021 | 33387578 | PubTator, text mining | PubMed |
| Traditional Chinese medicine combined with pulmonary drug delivery system and idiopathic pulmonary fibrosis: Rationale and therapeutic potential. | Biomed Pharmacother | 2021 | 33378971 | PubTator, text mining | PubMed |
| Idiopathic pulmonary fibrosis: Disease mechanisms and drug development. | Pharmacol Ther | 2021 | 33359599 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/871/papers?page=56